Beyond Air, Inc. Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
Beyond Air, Inc. (XAIR) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $10.00 thousand as of 2021-03-31, per its 10-Q filed 2022-02-10.
Discontinued › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2022-02-10
- 2021-03-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $10.00K; Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year as first filed $28.56K.
- 2020-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $19.04K.
- 2020-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $28.56K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year as first filed |
|---|---|---|
| 2021-03-31 | $10.00K 10-Q · filed 2022-02-10 | $28.56K 10-Q · filed 2021-08-10 |
| 2020-09-30 | $19.04K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $28.56K 10-Q · filed 2020-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |